Comment: Rifampin-Resistant Staphylococcus aureus Bacteremia in a Patient on Chronic Rifaximin

Abstract

Get full access to this article

View all access options for this article.

References

Lewis

Khan

Patel

Rifampin-resistant Staphylococcus aureus bacteremia in a patient on chronic rifaximin. Ann Pharmacother. 2017;51:617-618.

Tandon

Delisle

Topal

Garcia-Tsao

High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol. 2012;10:1291-1298.

Howden

Ward

Charles

et al . Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis. 2004;38:521-528.

Valentin

Leitner

Rohn

et al . Rifaximin intake leads to emergence of rifampin-resistant staphylococci. J Infect. 2011;62:34-38.

DuPont

Wolf

Israel

Pimentel

Antimicrobial susceptibility of Staphylococcus isolates from the skin of patients with diarrhea-predominant irritable bowel syndrome treated with repeat courses of rifaximin. Antimicrob Agents Chemother. 2017;61:e02165-16.